BackAutolus Therapeutics plc Overview
Autolus Therapeutics plc - ADR

Autolus Therapeutics plc Target Price

Autolus Therapeutics plc target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.24

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-11-18Goldman SachsGraig Suvannavejh$7.6239.3% upsideOpen
2024-05-20Wells FargoYanan Zhu$8257.1% upsideOpen
2024-04-08Truist FinancialAsthika Goonewardene$11391.1% upsideOpen
2024-03-15Truist FinancialAsthika Goonewardene$10346.4% upsideOpen

Autolus Therapeutics plc (AUTL) FAQ

Stockcircle tracks target price for Autolus Therapeutics plc (AUTL), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Autolus Therapeutics plc's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main AUTL overview so you can move from this figure to the surrounding analysis quickly.